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Nasal Chondromesenchymal
Hamartoma: CT and MR Imaging
Findings
We report CT and MR imaging findings for a case of nasal chondromesenchy-
mal hamartoma occurring in a 19-month-old boy. A nasal chondromesenchymal
hamartoma is a rare benign pediatric hamartoma that can simulate malignancy.
Although rare, knowledge of this entity is essential to avoid potentially harmful
therapies.
nasal chondromesenchymal hamartoma (NCMH) is a rare benign
hamartoma of the sinonasal tract, predominantly involving infants under
one year of age (1). To date, only 25 cases have been reported in the
English literature (1-10). Although the clinical, histopathologic, and CT features have
well been described, only limited descriptions of the MR imaging findings have been
reported in only a few cases (6-8, 10). We report the CT and MR imaging findings for
a case of NCMH occurring in a 19-month-old boy.
CASE REPORT
A 19-month-old previously healthy boy presented with an 8-month history of
watery rhinorrhea and nasal obstruction. The boy was born at full term by transvagi-
nal delivery. Upon examination, the left nasal cavity was obstructed by a large
polypoid mass. All other physical findings and laboratory tests were unremarkable. 
CT scans revealed a 2.7 × 3.5 cm well-defined, expansile mass in the left nasal
cavity, extending to the anterior ethmoid sinus. The mass caused pressure remodeling
of the adjacent bones without evidence of frank destruction or orbital and intracranial
invasion. The results of the precontrast CT scans indicated that the mass was isodense
with the cerebral cortex, without evidence of calcification. After contrast enhance-
ment, the lesion demonstrated only minimal enhancement (Fig. 1A). We performed
MR imaging to further characterize the internal architecture and found that the signal
intensity of the lesion was homogeneously isointense with the cerebral cortex on T1-
weighted images (Fig. 1B) and heterogeneously hyperintense on T2-weighted images.
The T2-weighted images also showed a peripheral small area of bright signal intensity
(Fig. 1C). After contrast enhancement, the majority of the lesion showed a mild diffuse
heterogeneous enhancement. The small area of bright signal intensity on the T2-
weighted images was seen as a non-enhancing cystic lesion (Fig. 1D).
The patient underwent endoscopic sinus surgery, which revealed a pink-tan soft
tissue mass. Resection of the mass was carried out in a piecemeal manner.
Microscopically, the lesion consisted of multiple cartilage islands in a myxoid stroma
containing spindle cells in a storiform pattern (Fig. 1E). The immunohistochemical
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Astaining using a standard immunoperoxidase technique was
positive for smooth muscle actin and S-100, and negative
for cytokeratin. On the basis of these microscopic and
immunohistochemical findings, the diagnosis of the NCMH
was made. Upon follow-up MRI examinations obtained
one year and four years post-surgery, we found a small
lesion in the left ethmoid sinus that had signal characteris-
tics and enhancement pattern which were consistent with
the original mass. Although stable, the differentiation
between residual tumor and mucosal reaction was difficult.
Endoscopic surgery was repeated and the lesion proved to
be same histology as the original NCMH. At present, the
patient is free of disease for the last 10 months.
DISCUSSION
An NCMH is a rare benign tumefactive process arising in
the nasal cavity and/or paranasal sinuses and occurs
predominantly in infants. In 1998, McDermott et al. (1)
suggested the term ‘nasal chondromesenchymal
hamartoma’ as a distinct pathologic entity that showed the
characteristic histologic features of mixed stromal and
chondroid tissue in various proportions, reminiscent of the
mesenchymal hamartoma of the chest wall. Before then,
an NCMH has been described under the various names,
such as chondroid hamartoma, mesenchymoma, and nasal
hamartoma (1, 4-7, 10). To date, only 25 cases have been
CT and MRI Findings of Nasal Chondromesenchymal Hamartoma
Korean J Radiol 10(4), Jul/Aug 2009 417
ABC
Fig. 1. Case of nasal chondromesenchymal hamartoma in 19-month-old boy.
A. Axial postcontrast CT scan shows well-defined, minimally enhancing, expansile mass in left nasal cavity, extending to anterior
ethmoid sinus. Thinning of adjacent bones caused by pressure remodeling is observed without evidence of frank destruction. Nasal
septum is also displaced to right. Also noted is opacification of left maxillary sinus due to obstruction by mass. On precontrast CT scans,
mass was isodense to cerebral cortex without evidence of intralesional calcification (not shown).
B. Coronal T1-weighted MR image demonstrates homogeneously isointense mass, compared with cerebral cortex.
C. Coronal fat-suppressed T2-weighted MR image demonstrates heterogeneously hyperintense mass, in relation to cerebral cortex,
containing small area of bright signal intensity peripherally (arrow). Although lesion abuts orbit and anterior cranial base, direct extension
of lesion to orbit and intracranial cavity is not evident.
D. Coronal contrast-enhanced fat-suppressed T1-weighted MR image shows mild, diffuse heterogeneous enhancement of lesion. Small
area of bright signal intensity seen on T2-weighted image is non-enhancing cystic component (arrow). Note fluid-filled left maxillary sinus
on B-D.
E. Photomicrograph shows tumor consisting of multiple chondromyxoid islands (I) in spindle cell stroma (Hematoxylin & Eosin staining,
× 100).
DEreported in the English literature (1-10). The pathogenesis
of NCMH is still unknown. Although originally thought to
be developmental or congenital, it seems unlikely because
there are documented cases that affect adults with an
asymptomatic childhood. It may be that the tumor is
caused by an underlying genetic predisposition in combina-
tion with the proper stimulation (4). This stimulation could
be environmental and may be linked to chronic inflamma-
tion or hormones (5).
A review of the 26 cases reported in the literature
including the present case indicate that NCMHs occur
predominantly in males (19 male and 7 female patients)
and infants under one year old (15 patients). The remain-
ing 11 patients, including our patient, ranged between 19
months to 69 years of age (1-5). The clinical manifesta-
tions depend on the size and location of the lesion and
include respiratory and feeding difficulties, rhinorrhea,
epistaxis, visual disturbances, and otitis media.
Occasionally, ophthalmologic signs such as ophthalmople-
gia, proptosis, ptosis, hypotropia, and enophthalmos can
result from the orbital involvement of the tumor (3, 5, 9,
10). An intracranial extension can result in neurologic signs
such as hydrocephalus and oculomotor disturbances (5). To
date, there have been no reported cases of malignant
transformation.
Microscopically, an NCMH is characterized by a variety
of mesenchymal components with a focally lobular
architecture. The most prominent components are irregular
islands of mature and immature hyaline cartilage with
occasional binucleated chondrocytes. The islands of
cartilage are well demarcated from the surrounding
stromal tissues, which have a myxoid background and
consist of a relatively bland and compact spindle cell
population with variable cellularity (1, 5). To date, no
atypical mitotic figures or malignant characteristics have
been found. However, reactive bone, small thick-walled
vessels, cystic formation, and erythrocyte-filled spaces,
have been reported (1, 3). The immunohistochemistry
characteristics show positivity to smooth muscle actin, S-
100, vimentin, KP-1, and Leu-7, while immunoreactivities
for cytokeratin, epithelial membrane antigen, and desmin
are negative (5, 6).
Currently, the treatment of choice for an NCMH is
complete surgical excision (1, 5, 10). If the lesion is
confined to the nasal cavity, it is often amenable to
endoscopic surgery. However, the infiltrative nature of the
lesion can make it difficult to obtain clean margins (5).
Recurrence of an NCMH after surgery has been reported
in patients with incomplete resections or microscopic
deposits of residual tumor (1, 7). Although radiation
therapy and chemotherapy have been applied for lesions
that are not completely resected (5), limited clinical experi-
ence makes it difficult to conclude how to treat residual or
unresectable lesions at this moment.
Diagnostic imaging is useful to evaluate the status of the
adjacent structures such as the paranasal sinuses, orbit, and
intracranial cavity. Although benign, an NCMH may
reveal an aggressive feature with bony erosion, thinning,
and displacement, and can raise the suspicion for
malignancy. Intracranial extension through the cribriform
plate is not infrequent (3, 5, 7, 10). However, frank bony
destruction as seen in malignant tumors is not a feature of
NCMH (3). Upon imaging, an NCMH is typically seen as a
nonencapsulated, poorly defined mass often with cystic
components (3, 7). Half of the cases are reported to
contain calcifications on CT scans (5). The MR imaging
findings of an NCMH have been reported in several
patients, mostly in non-radiology journals (2, 6-10).
Accordingly, the signal characteristics and enhancement
patterns are not specifically described in most cases. In our
case, the signal intensity was homogeneously isointense to
the cerebral cortex on T1-weighted images and heteroge-
neously hyperintense on T2-weighted images. These signal
intensities were thought to be ascribed to abundant stromal
myxoid tissues with relatively low cellularity. Cystic
changes can also be well demonstrated as areas of bright
signal intensity in relation to the cerebrospinal fluid. In
certain cases, the cystic change is so extensive that the
tumor can masquerade as a meningoencephalocele (8). In
addition, the enhancement patterns can be variable (6, 7,
10). Although our case demonstrated only mild enhance-
ment, there are tumors with prominent vascular prolifera-
tion that mimic an angiofibroma histologically (7).
Different tissue components and vascularities might cause
varied enhancement patterns on imaging.
Upon imaging, differential diagnoses for a pediatric
sinonasal mass are lengthy and includes hemangioma,
angiofibroma, nasal glioma, inverted papilloma, giant cell
reparative granuloma, ossifying fibroma, chondro-osseous
respiratory adenomatoid hamartoma, aneurysmal bone
cyst, rhabdomyosarcoma, esthesioneuroblastoma, and a
chondrosarcoma, with the latter two usually seen only in
adolescents (5). Although a case of hypervascular NCMH
has been reported, marked enhancement as seen in a
hemangioma or angiofibroma is unusual for NCMH.
Compared with the cerebral cortex, a nasal glioma usually
demonstrates an isointense signal on both the T1- and T2-
weighted MR images. Sinonasal inverted papilloma
predominantly occurs in adults and is characterized by a
convoluted cerebriform pattern on T2-weighted and
contrast-enhanced T1-weighted MR images. If the nasal
mass contains internal calcifications, a differential diagnosis
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can be narrowed to ossifying fibroma, chondro-osseous
respiratory adenomatoid hamartoma, and chondroid
tumor.
In conclusion, we report the CT and MR imaging features
of an NCMH, a rare benign hamartoma, generally in
pediatric patients. Knowledge of this entity is essential to
avoid potentially harmful therapies, since it often simulates
malignancy on imaging.
References
1. McDermott MB, Ponder TB, Dehner LP. Nasal chondromes-
enchymal hamartoma: an upper respiratory tract analogue of
the chest wall mesenchymal hamartoma. Am J Surg Pathol
1998;22:425-433
2. Alrawi M, McDermott M, Orr D, Russell J. Nasal chondrome-
senchymal hamartoma presenting in an adolescent. Int J Pediatr
Otorhinolaryngol 2003;67:669-672
3. Norman ES, Bergman S, Trupiano JK. Nasal chondromesenchy-
mal hamartoma: report of a case and review of the literature.
Pediatr Dev Pathol 2004;7:517-520
4. Ozolek JA, Carrau R, Barnes EL, Hunt JL. Nasal chondromes-
enchymal hamartoma in older children and adults: series and
immunohistochemical analysis. Arch Pathol Lab Med
2005;129:1444-1450
5. Johnson C, Nagaraj U, Esguerra J, Wasdahl D, Wurzbach D.
Nasal chondromesenchymal hamartoma: radiographic and
histopathologic analysis of a rare pediatric tumor. Pediatr
Radiol 2007;37:101-104
6. Kim DW, Low W, Billman G, Wickersham J, Kearns D.
Chondroid hamartoma presenting as a neonatal nasal mass. Int J
Pediatr Otorhinolaryngol 1999;47:253-259
7. Hsueh C, Hsueh S, Gonzalez-Crussi F, Lee T, Su J. Nasal
chondromesenchymal hamartoma in children: report of 2 cases
with review of the literature. Arch Pathol Lab Med
2001;125:400-403
8. Kim B, Park SH, Min HS, Rhee JS, Wang KC. Nasal
chondromesenchymal hamartoma of infancy clinically mimick-
ing meningoencephalocele. Pediatr Neurosurg 2004;40:136-140
9. Silkiss RZ, Mudvari SS, Shetlar D. Ophthalmologic presentation
of nasal chondromesenchymal hamartoma in an infant. Ophthal
Plast Reconstr Surg 2007;23:243-244
10. Finitsis S, Giavroglou C, Potsi S, Constantinidis I, Mpaltatzidis
A, Rachovitsas D, et al. Nasal chondromesenchymal hamartoma
in a child. Cardiovasc Intervent Radiol 2009;32:593-597